Screener
Calumet, Inc. CLMT Specialty Products and Solutions — Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Calumet, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Calumet, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0002013745-26-000024
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Sales | $1,445.1 | $1,026.6 | $2,474.9 | $2,020.5 |
| Cost of sales | 1,426.8 | 1,070.2 | 2,544.0 | 2,145.5 |
| Gross profit (loss) | 18.3 | (43.6) | (69.1) | (125.0) |
| Operating costs and expenses: | ||||
| Selling | 13.5 | 12.2 | 25.8 | 24.5 |
| General and administrative | 39.4 | 41.1 | 105.4 | 53.2 |
| Gain on sale of business | — | — | — | (62.2) |
| Other operating expense | 5.4 | 4.1 | 11.0 | 9.2 |
Item 1. Financial Statements
FAQ
- What is Calumet, Inc.'s specialty products and solutions — sales?
- Calumet, Inc. (CLMT) reported specialty products and solutions — sales of $1.02B in Q2 2026.
- What does specialty products and solutions — sales mean?
- This represents the total revenue generated from the sale of specialty products, including base oils, solvents, and waxes, within the designated business segment. It serves as the primary indicator of market demand and pricing power for the company's specialty product portfolio. Growth in this metric reflects successful market penetration and product mix optimization.
Ask your AI about Calumet, Inc.'s specialty products and solutions — sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude